147 related articles for article (PubMed ID: 18975316)
1. Myotonic dystrophy type 2 found in two of sixty-three persons diagnosed as having fibromyalgia.
Auvinen S; Suominen T; Hannonen P; Bachinski LL; Krahe R; Udd B
Arthritis Rheum; 2008 Nov; 58(11):3627-31. PubMed ID: 18975316
[TBL] [Abstract][Full Text] [Related]
2. No relevant excess prevalence of myotonic dystrophy type 2 in patients with suspected fibromyalgia syndrome.
van Vliet J; Verrips A; Tieleman AA; Scheffer H; Cats HA; den Broeder AA; van Engelen BG
Neuromuscul Disord; 2016 Jun; 26(6):370-3. PubMed ID: 27132119
[TBL] [Abstract][Full Text] [Related]
3. Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy.
Logigian EL; Ciafaloni E; Quinn LC; Dilek N; Pandya S; Moxley RT; Thornton CA
Muscle Nerve; 2007 Apr; 35(4):479-85. PubMed ID: 17230537
[TBL] [Abstract][Full Text] [Related]
4. Development and Validation of a New Molecular Diagnostic Assay for Detection of Myotonic Dystrophy Type 2.
Valaperta R; Lombardi F; Cardani R; Fossati B; Brigonzi E; Merli I; Sansone V; Merletti G; Spina E; Meola G; Costa E
Genet Test Mol Biomarkers; 2015 Dec; 19(12):703-9. PubMed ID: 26505324
[TBL] [Abstract][Full Text] [Related]
5. Myotonic dystrophy: from bench to bedside.
Johnson NE; Heatwole CR
Semin Neurol; 2012 Jul; 32(3):246-54. PubMed ID: 23117949
[TBL] [Abstract][Full Text] [Related]
6. Biomolecular diagnosis of myotonic dystrophy type 2: a challenging approach.
Meola G; Biasini F; Valaperta R; Costa E; Cardani R
J Neurol; 2017 Aug; 264(8):1705-1714. PubMed ID: 28550479
[TBL] [Abstract][Full Text] [Related]
7. A non-DM1, non-DM2 multisystem myotonic disorder with frontotemporal dementia: phenotype and suggestive mapping of the DM3 locus to chromosome 15q21-24.
Le Ber I; Martinez M; Campion D; Laquerrière A; Bétard C; Bassez G; Girard C; Saugier-Veber P; Raux G; Sergeant N; Magnier P; Maisonobe T; Eymard B; Duyckaerts C; Delacourte A; Frebourg T; Hannequin D
Brain; 2004 Sep; 127(Pt 9):1979-92. PubMed ID: 15215218
[TBL] [Abstract][Full Text] [Related]
8. Muscle pathology in myotonic dystrophy: light and electron microscopic investigation in eighteen patients.
Nadaj-Pakleza A; Lusakowska A; Sułek-Piątkowska A; Krysa W; Rajkiewicz M; Kwieciński H; Kamińska A
Folia Morphol (Warsz); 2011 May; 70(2):121-9. PubMed ID: 21630234
[TBL] [Abstract][Full Text] [Related]
9. Clinical score for early diagnosis of myotonic dystrophy type 2.
Ivanovic V; Peric S; Pesovic J; Tubic R; Bozovic I; Petrovic Djordjevic I; Savic-Pavicevic D; Meola G; Rakocevic-Stojanovic V
Neurol Sci; 2023 Mar; 44(3):1059-1067. PubMed ID: 36401657
[TBL] [Abstract][Full Text] [Related]
10. Musculoskeletal pain in patients with myotonic dystrophy type 2.
George A; Schneider-Gold C; Zier S; Reiners K; Sommer C
Arch Neurol; 2004 Dec; 61(12):1938-42. PubMed ID: 15596616
[TBL] [Abstract][Full Text] [Related]
11. Strong association between myotonic dystrophy type 2 and autoimmune diseases.
Tieleman AA; den Broeder AA; van de Logt AE; van Engelen BG
J Neurol Neurosurg Psychiatry; 2009 Nov; 80(11):1293-5. PubMed ID: 19864666
[TBL] [Abstract][Full Text] [Related]
12. [Myotonic dystrophy type 2].
Kimura T
Rinsho Shinkeigaku; 2012; 52(11):1267-9. PubMed ID: 23196585
[TBL] [Abstract][Full Text] [Related]
13. Qualitative and Quantitative Aspects of Pain in Patients With Myotonic Dystrophy Type 2.
van Vliet J; Tieleman AA; Verrips A; Timmerman H; van Dongen RTM; van Engelen BGM; Wilder-Smith OHG
J Pain; 2018 Aug; 19(8):920-930. PubMed ID: 29601898
[TBL] [Abstract][Full Text] [Related]
14. Graves' disease and celiac disease in a patient with myotonic dystrophy type 2.
Damen MJ; van der Meer A; Voermans NC; Tieleman AA
Neuromuscul Disord; 2018 Oct; 28(10):878-880. PubMed ID: 30197184
[TBL] [Abstract][Full Text] [Related]
15. Clinical, electrophysiologic and pathologic findings in 10 patients with myotonic dystrophy 2.
Dabby R; Sadeh M; Herman O; Leibou L; Kremer E; Mordechai S; Watemberg N; Frand J
Isr Med Assoc J; 2011 Dec; 13(12):745-7. PubMed ID: 22332444
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic variability and molecular genetics in proximal myotonic myopathy.
Papadimas GK; Kekou K; Papadopoulos C; Kararizou E; Kanavakis E; Manta P
Muscle Nerve; 2015 May; 51(5):686-91. PubMed ID: 25186227
[TBL] [Abstract][Full Text] [Related]
17. Myotonic Dystrophy Type 2 - Data from the Serbian Registry.
Bozovic I; Peric S; Pesovic J; Bjelica B; Brkusanin M; Basta I; Bozic M; Sencanic I; Marjanovic A; Brankovic M; Savic-Pavicevic D; Rakocevic-Stojanovic V
J Neuromuscul Dis; 2018; 5(4):461-469. PubMed ID: 30248060
[TBL] [Abstract][Full Text] [Related]
18. New methods for molecular diagnosis and demonstration of the (CCTG)n mutation in myotonic dystrophy type 2 (DM2).
Sallinen R; Vihola A; Bachinski LL; Huoponen K; Haapasalo H; Hackman P; Zhang S; Sirito M; Kalimo H; Meola G; Horelli-Kuitunen N; Wessman M; Krahe R; Udd B
Neuromuscul Disord; 2004 Apr; 14(4):274-83. PubMed ID: 15019706
[TBL] [Abstract][Full Text] [Related]
19. Assessing the influence of age and gender on the phenotype of myotonic dystrophy type 2.
Montagnese F; Mondello S; Wenninger S; Kress W; Schoser B
J Neurol; 2017 Dec; 264(12):2472-2480. PubMed ID: 29086017
[TBL] [Abstract][Full Text] [Related]
20. Quality of life in patients with myotonic dystrophy type 2.
Rakocevic Stojanovic V; Peric S; Paunic T; Pesovic J; Vujnic M; Peric M; Nikolic A; Lavrnic D; Savic Pavicevic D
J Neurol Sci; 2016 Jun; 365():158-61. PubMed ID: 27206898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
